Provided by Tiger Fintech (Singapore) Pte. Ltd.

Nurix Therapeutics

11.61
+0.15001.31%
Post-market: 11.610.00000.00%16:20 EDT
Volume:2.50M
Turnover:29.63M
Market Cap:885.10M
PE:-4.14
High:12.38
Open:11.97
Low:11.55
Close:11.46
Loading ...
Apr 08, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 08, 2025

Major Issues Report

Form 8-K - Current report
Mar 14, 2025

Correspondence

Form CORRESP - Correspondence
Mar 13, 2025

Major Issues Report

Form 8-K - Current report
Mar 03, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 31, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 28, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Jan 28, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Jan 28, 2025

Major Issues Report

Form 8-K - Current report
Jan 13, 2025

Major Issues Report

Form 8-K - Current report
Jan 02, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 10, 2024

Major Issues Report

Form 8-K - Current report
Dec 02, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 08, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Nov 04, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 01, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 01, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities